Organovo Holdings, Inc. (ONVO)

[rongreen]

Taylor Crouch, from the recent earnings call:

"As I consider our one year plan, we're focused on two clear objectives. First, rapidly growing adoption of our liver and kidney tissue research services, which include ongoing pioneering investments and dynamic disease modeling and second hitting key preclinical development milestones for our liver therapeutic tissue program. "

As I read that, skin isn't going to be a focus at this time. Organovo, if they were asked to bid on Inmed's request, probably said "Thanks, but no thanks."